Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection.
Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection.
复制标题
接触注射药物或酒精对艾滋病毒和丙型肝炎病毒合并感染中抗原特异性免疫反应的影响。
DOI:
10.1086/511990
复制
发表时间:
2007
期刊:
影响因子:
--
通讯作者:
Koziel,MargaretJames
中科院分区:
文献类型:
--
作者:
Graham,CamillaS;Wells,Annalee;Edwards,ErikaM;Herren,Timothy;Tumilty,Sheila;Stuver,SherriO;Samet,JeffreyH;Nunes,David;HorsburghJr,CRobert;Koziel,MargaretJames
Background.Ongoing substance use is a potential confounder for immunological studies on hepatitis C virus (HCV), but there is little in the literature regarding the effects of injection drug use (IDU) or alcohol on HCVspecific immune responses. We wanted to determine whether IDU or alcohol affected immune responses in HCVinfected and human immunodeficiency virus (HIV)/HCV coinfected subjects.Methods.Eight-four subjects with HIV/HCV and 57 with HCV were classified as either injection drug users, drinkers, or nonusers based on questionnaire results. Immune responses were studied with enzyme-linked immunosorbent spot assay for interferon (IFN)-γ, interleukin (IL)-10, and tumor necrosis factor (TNF)-α against HCV proteins Core, NS3, and NS5 and recall antigens.Results.Subjects with HIV/HCV, in aggregate, had significantly lower HCV-specific IFN-γ and TNF-α responses than subjects with HCV. However, HIV/HCV injection drug users had HCV-specific IFN-γ and IL-10 responses that were similar to those of HCV injection drug users and were significantly higher than in nonusers with HIV/HCV. Conversely, subjects who drank alcohol had similar immune responses to those who were abstinent, among both subjects with HIV/HCV and subjects with HCV.Conclusions.Studies that examine IFN-γ or IL-10 immune responses in HIV/HCV-coinfected orHCV-infected persons need to consider current IDU. Alcohol, at levels consumed in this cohort, does not appear to have as much of an effect on antigen-specific immune responses.